Table 1 Clinical characteristics of the studied groups
Variables | N.C. (N = 26) | AHB (N = 9) | MCHB (N = 23) | SCHB (N = 17) |
|---|---|---|---|---|
Age (year) | 30.2 ± 5.4 | 32.7 ± 13.5 | 33.1 ± 11.4 | 42.8 ± 13.1 |
Sex | 69.2 | 88.9 | 70.0 | 70.6 |
HBsAg (%) | 0 | 77.8 | 100 | 100 |
HBsAb (%) | 61.5 | 22.2 | 0 | 0 |
HBeAg (%) | 0 | 77.8 | 50 | 35.7 |
HBeAb (%) | 3.8 | 22.2 | 50 | 71.4 |
HBcAb (%) | 34.6 | 100 | 100 | 100 |
Log HBV DNA | NA | 4.66 ± 2.95 | 6.87 ± 1.59 | 4.34 ± 3.07 |
ALT (IU/L) | 15.3 ± 9.2 | 1197.5 ± 804.7 | 360.6 ± 344.6 | 487.8 ± 775.9 |
AST (IU/L) | 11.7 ± 6.8 | 537.1 ± 539.0 | 241.7 ± 261.3 | 417.2 ± 597.1 |
Bilirubin (umol/L) | 14 ± 11.1 | 113.2 ± 105.6 | 65.6 ± 55.2 | 332.5 ± 179.6 |
INR | NA | 1.14 ± 0.26 | 1.02 ± 0.12 | 2.32 ± 0.85 |